A pharmaceutical comprising 5-[7[2-(5 methyl-2-phenyl-oxazole-4-yl)-ethoxy] benzothiophene-4-methyl]-2,4 thiazolidinedione
PK140298AUndetermined Publication Date: 2009-11-18F HOFFMANN LA ROCHE & CO AG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK200100579
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2009-11-18
Abstract
The present invention relates to a composition comprising 0.2 to 10% w / w residual water or a mixture of water / ethanol, 1 to 96% w / w orlistat, 3.7 to 98.7% maltodextrin and 0.1 to 95.1 w / w of one or more pharmaceutically acceptable excipients.
Need to check novelty before this filing date? Find Prior Art